Pfizer Supplier Finance Program Obligations decreased by 9.8% to $518.00M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase may signal aggressive working capital management or a reliance on external financing to delay cash outflows.
This represents amounts owed to suppliers that have been financed through third-party financial institutions, often refe...
Increasingly common in consumer goods, though transparency varies significantly between companies.
supplier_finance_obligations| Q4 '22 | Q1 '23 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $849.00M | $755.00M | $574.00M | $518.00M |
| QoQ Change | — | -11.1% | -24.0% | -9.8% |